Page 8 - Ipca Laboratories News Today

Chloroquine Phosphate API Market Analysis and Future Prospects for 2030

The stock rose from Rs 731 on 20 June to Rs 913 recorded on 20 September, which translates into an upside of 24% in 3 months. It hit a fresh 52-week high of Rs 954 on 18 September but witnessed some profit-taking thereafter, largely in line with the trend seen in broader markets

Ipca Labs acquired 33.38 percent of Unichem in August which triggered an open offer. Ipca Labs received the approval of the Competition Commission of India for this acquisition on July 27, 2023

Ipca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 23532.33 Crore) operating in Pharmaceuticals sector.

​This means the average traded quantity of the stock for five days along with its cumulative open interest has increased whereas the price has decreased

On the weekly options front, the maximum Call OI is placed at 20,200 and then towards 20,500 strikes while the maximum Put OI is placed at 20100 and then towards 20000 strikes.

A short build-up was seen in 61 stocks, including HDFC Bank, Reliance Industries, Hero MotoCorp, Berger Paints, and Vedanta. An increase in OI along with a fall in price points to a build-up of short positions

The short build-up was seen in 79 stocks. These included Ipca Laboratories, Delta Corp, SBI Card, NALCO, and Vodafone Idea. An increase in OI along with a fall in price points to a build-up of short positions.

Ipca Labs has been trading under pressure since last two years and a few weeks ago the stock marked its 52-week low of Rs 669.80 as well in the month of May 2023.

The market will remain shut on September 19 on account of Ganesh Chaturthi